2018-2023 Global Peptide Therapeutics Consumption Market Report
Published On: August 2018
 
Report ID:310926
 
 
Pages: 166




In this report, Fior Markets covers the present scenario (with the base year being 2017) and the growth prospects of global Peptide Therapeutics market for 2018-2023.

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

In this report, we study the peptide-based drugs.

In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.

The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.

Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.

Over the next five years, Fior Markets projects that Peptide Therapeutics will register a 5.5% CAGR in terms of revenue, reach US$ 39300 million by 2023, from US$ 28500 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, Fior Markets considers value and volume generated from the sales of the following segments:

Segmentation by product type:

Injection

Oral

Other

Segmentation by application:

Cancer

Metabolic Disorders

Central Nervous System

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

Sanofi

Teva

Novo Nordisk

Takeda

Eli Lilly

AstraZeneca

Novartis

Shire

AbbVie

Ipsen

Allergan

Ferring

Merck

The Medicines

Roche

J & J

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Peptide Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Peptide Therapeutics market by identifying its various subsegments.

Focuses on the key global Peptide Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Peptide Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Peptide Therapeutics submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Peptide Therapeutics Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Peptide Therapeutics Consumption 2013-2023

2.1.2 Peptide Therapeutics Consumption CAGR by Region

2.2 Peptide Therapeutics Segment by Type

2.2.1 Injection

2.2.2 Oral

2.2.3 Other

2.3 Peptide Therapeutics Consumption by Type

2.3.1 Global Peptide Therapeutics Consumption Market Share by Type (2013-2018)

2.3.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)

2.3.3 Global Peptide Therapeutics Sale Price by Type (2013-2018)

2.4 Peptide Therapeutics Segment by Application

2.4.1 Cancer

2.4.2 Metabolic Disorders

2.4.3 Central Nervous System

2.4.4 Other

2.5 Peptide Therapeutics Consumption by Application

2.5.1 Global Peptide Therapeutics Consumption Market Share by Application (2013-2018)

2.5.2 Global Peptide Therapeutics Value and Market Share by Application (2013-2018)

2.5.3 Global Peptide Therapeutics Sale Price by Application (2013-2018)

3 Global Peptide Therapeutics by Players

3.1 Global Peptide Therapeutics Sales Market Share by Players

3.1.1 Global Peptide Therapeutics Sales by Players (2016-2018)

3.1.2 Global Peptide Therapeutics Sales Market Share by Players (2016-2018)

3.2 Global Peptide Therapeutics Revenue Market Share by Players

3.2.1 Global Peptide Therapeutics Revenue by Players (2016-2018)

3.2.2 Global Peptide Therapeutics Revenue Market Share by Players (2016-2018)

3.3 Global Peptide Therapeutics Sale Price by Players

3.4 Global Peptide Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Peptide Therapeutics Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Peptide Therapeutics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Peptide Therapeutics by Regions

4.1 Peptide Therapeutics by Regions

4.1.1 Global Peptide Therapeutics Consumption by Regions

4.1.2 Global Peptide Therapeutics Value by Regions

4.2 Americas Peptide Therapeutics Consumption Growth

4.3 APAC Peptide Therapeutics Consumption Growth

4.4 Europe Peptide Therapeutics Consumption Growth

4.5 Middle East & Africa Peptide Therapeutics Consumption Growth

5 Americas

5.1 Americas Peptide Therapeutics Consumption by Countries

5.1.1 Americas Peptide Therapeutics Consumption by Countries (2013-2018)

5.1.2 Americas Peptide Therapeutics Value by Countries (2013-2018)

5.2 Americas Peptide Therapeutics Consumption by Type

5.3 Americas Peptide Therapeutics Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Peptide Therapeutics Consumption by Countries

6.1.1 APAC Peptide Therapeutics Consumption by Countries (2013-2018)

6.1.2 APAC Peptide Therapeutics Value by Countries (2013-2018)

6.2 APAC Peptide Therapeutics Consumption by Type

6.3 APAC Peptide Therapeutics Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Peptide Therapeutics by Countries

7.1.1 Europe Peptide Therapeutics Consumption by Countries (2013-2018)

7.1.2 Europe Peptide Therapeutics Value by Countries (2013-2018)

7.2 Europe Peptide Therapeutics Consumption by Type

7.3 Europe Peptide Therapeutics Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Peptide Therapeutics by Countries

8.1.1 Middle East & Africa Peptide Therapeutics Consumption by Countries (2013-2018)

8.1.2 Middle East & Africa Peptide Therapeutics Value by Countries (2013-2018)

8.2 Middle East & Africa Peptide Therapeutics Consumption by Type

8.3 Middle East & Africa Peptide Therapeutics Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Peptide Therapeutics Distributors

10.3 Peptide Therapeutics Customer

11 Global Peptide Therapeutics Market Forecast

11.1 Global Peptide Therapeutics Consumption Forecast (2018-2023)

11.2 Global Peptide Therapeutics Forecast by Regions

11.2.1 Global Peptide Therapeutics Forecast by Regions (2018-2023)

11.2.2 Global Peptide Therapeutics Value Forecast by Regions (2018-2023)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Peptide Therapeutics Forecast by Type

11.8 Global Peptide Therapeutics Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Company Details

12.1.2 Peptide Therapeutics Product Offered

12.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.1.4 Main Business Overview

12.1.5 Sanofi News

12.2 Teva

12.2.1 Company Details

12.2.2 Peptide Therapeutics Product Offered

12.2.3 Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.2.4 Main Business Overview

12.2.5 Teva News

12.3 Novo Nordisk

12.3.1 Company Details

12.3.2 Peptide Therapeutics Product Offered

12.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.3.4 Main Business Overview

12.3.5 Novo Nordisk News

12.4 Takeda

12.4.1 Company Details

12.4.2 Peptide Therapeutics Product Offered

12.4.3 Takeda Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.4.4 Main Business Overview

12.4.5 Takeda News

12.5 Eli Lilly

12.5.1 Company Details

12.5.2 Peptide Therapeutics Product Offered

12.5.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.5.4 Main Business Overview

12.5.5 Eli Lilly News

12.6 AstraZeneca

12.6.1 Company Details

12.6.2 Peptide Therapeutics Product Offered

12.6.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.6.4 Main Business Overview

12.6.5 AstraZeneca News

12.7 Novartis

12.7.1 Company Details

12.7.2 Peptide Therapeutics Product Offered

12.7.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.7.4 Main Business Overview

12.7.5 Novartis News

12.8 Shire

12.8.1 Company Details

12.8.2 Peptide Therapeutics Product Offered

12.8.3 Shire Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.8.4 Main Business Overview

12.8.5 Shire News

12.9 AbbVie

12.9.1 Company Details

12.9.2 Peptide Therapeutics Product Offered

12.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.9.4 Main Business Overview

12.9.5 AbbVie News

12.10 Ipsen

12.10.1 Company Details

12.10.2 Peptide Therapeutics Product Offered

12.10.3 Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)

12.10.4 Main Business Overview

12.10.5 Ipsen News

12.11 Allergan

12.12 Ferring

12.13 Merck

12.14 The Medicines

12.15 Roche

12.16 J & J

13 Research Findings and Conclusion




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.